OSferionBiomaterials Selected as a Recipient of the FY2027 Intensive Support Program for Next-Generation Medical Device Development and Commercialization
News ReleaseOSferionBiomaterials Corp.OSferionBiomaterials Corp. (OSB), a member of OrthoActiVolution Holdings Inc. (OAV), was selected on July 21, 2026, as a recipient of the FY2027 Intensive Support Program for Next-Generation Medical Device Development and Commercialization, administered by the Fujinokuni Medical Town Promotion Organization.
The program is designed to revitalize Shizuoka Prefecture’s medical and healthcare industry by creating model cases of advanced medical device development led by highly capable local companies and encouraging broader participation by other innovative businesses.
Through this support, OAV and OSferionBiomaterials (OSB) will continue itheir efforts to develop high-performance medical devices and contribute to the growth of the medical and healthcare industry.
For more information (Japanese) (External Link): https://www.biomaterial.co.jp/news/199/
